GW788388 Hydrate
SIGMA/SML0116 - ≥98% (HPLC)
Synonym: 4-
Empirical Formula (Hill Notation): C25H23N5O2 · xH2O
Molecular Weight: 425.48 (anhydrous basis)
MDL Number: MFCD20527321
Linear Formula: C25H23N5O2 · xH2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C25H23N5O2.H2O/c31-25( |
| InChI key | VZRJMBZMFKADGR-UHFFFAOYSA |
| originator | GlaxoSmithKline |
| Quality Level | 100 ![]() |
| SMILES string | O.O=C(NC1CCOCC1)c2ccc(cc2 |
| solubility | DMSO: ≥8 mg/mL |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | GW788388 is a potent selective inhibitor of TGF-beta type I receptor [activin receptor-like kinase 5 (ALK5)]. GW788388 is orally available with a half-life of approximately 4 hours. |
| Biochem/physiol Actions: | TGFβ1 (ALK5) inhibitor; Potent, selective inhibitor of TGFβ signalling in vitro and renal fibrosis in vivo |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS06,GHS09 |
| Signal word | Danger |
| Hazard statements | H301 - H400 |
| Precautionary statements | P273 - P301 + P310 + P330 |
| Hazard Codes | T,N |
| Risk Statements | 25-50/53 |
| Safety Statements | 60-61 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |



